Two Onc Docs

Today’s episode is covering the treatment options for M0 castrate resistant prostate cancer as well as metastatic castrate-sensitive and castrate-resistant prostate cancer, including some 2023 updates.

We are diving into 2023 updates on our 2 part episode on localized and metastatic cancer. This episode will cover localized prostate cancer, as well as introduce biochemical recurrence.

Today’s episode is a 2023 update on the management of metastatic colon cancer. This will include an overview of molecular studies, treatment options and their toxicities.

Today’s episode is a 2023 update on what you need to know regarding early stage colon cancer. We will go over all the important details on the diagnosis, presentation, diagnostic work-up, staging, treatment, and surveillance.

This week’s episode will be focusing on hemolytic anemia. We will primarily focus on acquired forms of hemolytic anemia which include warm autoimmune hemolytic anemia (WAIHA), cold agglutinin disease (CAD), paroxysmal cold hemoglobinuria (PCH), and briefly cover a few other key differentials.

This week’s episode will be focusing on inherited platelet disorders. We will go over the important details on the roles of platelets, the  diagnosis of inherited platelet disorders through aggregation studies, as well as the treatment of these disorders.

This week’s episode will be focusing on one more of the myeloproliferative neoplasms, Primary Myelofibrosis (PMF). We will go over important details on the diagnosis, risk stratification  and treatment options.

This week’s episode will be focusing on Esophageal and Gastrosophageal Junction (GEJ) Cancers. We will go over high yield details on the risk factors, diagnosis, and treatment for both localized and metastatic esophageal cancer.

This week’s episode will be focusing on another one of the myeloproliferative neoplasms (MPN): Polycythemia Vera (PV). We will go over the important details on the diagnosis, risk stratification, and treatment.

This week’s episode is part 2 of our series in honor of Sarcoma Awareness Month. We will be focusing on Bone sarcomas. We will go over the important details on diagnosis, staging, subtypes and treatment of a few highly testable bone sarcomas. 

Since July is Sarcoma Awareness Month, we are starting a 2-part series on sarcomas. This week’s episode will be focusing on soft tissue sarcomas. We will go over the important details on the diagnosis, subtypes and treatment of a few of the highly testable soft tissue sarcomas.

This week is the final episode of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of localized ER+/HER-2- breast cancer and covering an oral abstract from the ASCO 2023 annual meeting,  the NATALEE Trial. We also cover some more statistics pearls that are important in oncology trials.

This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting,  the CONTACT03 Trial. We also cover subgroup analysis interpretation.

This week’s episode is part 1 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of locally advanced rectal cancer and covering a plenary session abstract from the ASCO 2023 annual meeting,  the PROSPECT Trial. We also cover the concept of non-inferiority trials.

This week’s episode will be focusing on the diagnosis and treatment of rectal cancer. We will go over important details on the diagnosis, staging and treatment of both locally advanced and metastatic rectal cancer.

ASCO 2023 is just around the corner and we are teaming up with The Fellow On Call to bring you a joint mini-series called “Paging Heme/Onc: Updates from ASCO 2023” where we’ll bring you brief, high-yield discussions of some of the research we found most interesting from this year’s conference.

This week’s episode is part 2 of our series focusing on transfusion medicine. We discuss indications for pre-transfusion protocols, as well as infectious and non-infectious, and acute & delayed risks of transfusions

This week’s episode is part 1 of a 2 part series focusing on transfusion medicine. In part 1, we cover important details on blood group systems, blood components, indications for these components, and quickly cover apharesis. 

This week’s episode will be focusing on thyroid cancers. We will go over details on the staging, breaking down the various types of thyroid cancers and of course the treatments for this disease group.

This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.

This week’s episode will be an introduction to plasma cell dyscrasias. We will cover the diagnostic criteria for MGUS and Smoldering Myeloma as well as introduce Multiple Myeloma.

Today we tackle inheritable bone marrow failure syndromes. We will go over the important details on the various types of testable bone marrow failure disorders including the key features of diagnosis and treatment.

This week’s episode will be focusing on cholangiocarcinoma, or biliary tract cancer. We will go over the testable high yield facts on the risk factors, diagnosis, and treatment of local and advanced cholangiocarcinoma.

This week’s episode will be focusing on syndromes of iron overload. We will go over important details on hemochromatosis and other related diseases, as well as iron chelation.

This week’s episode will be focusing on how we met, the future of the podcast, and different career paths in hematology and oncology. This is a very different style of episode and a special once because today is our one year anniversary of Two Onc Docs! We will back to our regular programming next week.